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Abstract
Methods for causal inference from observational data are an alternative for scenar-
ios where collecting counterfactual data or realizing a randomized experiment is not
possible. Adopting a stacking approach, our proposed method ParKCA combines
the results of several causal inference methods to learn new causes in applications
with some known causes and many potential causes. We validate ParKCA in two
Genome-wide association studies, one real-world and one simulated dataset. Our
results show that ParKCA can infer more causes than existing methods.
1 Introduction
The gold-standard of causal inference is based on experimental design, with randomized trials and
control groups. Recently, however, there is a rise of more data-driven methods, based on observational
data [23, 33, 58, 60, 24, 55, 48]. The primary motivations of these works are the lack of the full
experiment and counterfactual data, either because is too expensive or impossible to collect.
Expanding the problem definition, some applications, such as Driver Gene Discovery [46] or causation
in Earth Systems [38], have a few causes that are well known. So far, all the previously mentioned
techniques use known causes only for evaluation. To address this type of application, we propose
ParKCa: a method that uses the few known causes to learn new causes through the combination of
other causal discovery methods. The intuition is that ParKCa will learn how to identify causes based
on the outputs of the other methods (similar to ensemble learning) and a few known examples.
ParKCa has several advantages. First, leveraging several methods instead of using a single one can
minimize bias from specific approaches and highlights patterns common across the methods. Second,
it allows the use of known causes to help identify new causes. Third, this strategy is especially
suitable for applications with many possible causes. Finally, it also allows the combinations of several
datasets that share the same set of possible causes but might differ in the datatype or set of rows.
The proposed method ParKCa for causal inference with partially known causes is validated in a
simulated dataset and on the driver gene discovery application. The existence of associations between
cancer and specific genes is well accepted in the precision medicine field. However, the human body
has more than 20,000 genes, and not all genes are associated with cancer [46]. Hence, the challenge
is to recognize those genes that are associated with cancer spreading from the original site to other
areas of the body (metastasis) through causal inference. These genes are known as driver genes and
play an important role in cancer prevention and treatment.
There are many challenges around driver gene discovery. Progress in sequencing technology has
provided many good datasets, such as The Cancer Genome Atlas (TCGA). The cost to collect genetic
information from cancer patients is decreasing; however, it is still an expensive process [5]. The
consequence of these costs is the small size of available datasets, which is a limitation in the use of
certain machine learning methods that require large datasets. The number of columns (genes) is often
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Table 1: Toy example of the transposed input data (on the left) and output data (on the right) of our
application. Note that in the input data we have Y and in the outcome data, the known causes.
Gene 1 ... Gene V Y L1 L2 Known Cause
Patient 1 7.39 ... 1.60 0 Gene 1 -1.2 -2.4 1
... ... ... ... ... → ... ... ... ..
Patient J 3.25 ... 2.73 1 Gene V 0 12.3 0
much larger than the number of rows (patients), which poses an extra challenge for machine learning
models. Another challenge is the partially known dependence between genes due to pathways.
Pathways are sets of genes where the alteration or mutation in one gene can cause changes in other
genes that share the same pathway [53]. Some pathways are established and well explored, but
there is no guarantee that all existing pathways are known. Additionally, some elements that cause
cancer might not be included in the dataset. Examples of elements not observed are the structured
clinical information about the patient, such as their lab results and lifestyle. Finally, the last challenge
mentioned here is the lack of a well-defined training set, making the evaluation of results tricky. There
is no ‘true’ list of driver genes to evaluate the quality of the machine learning models [10, 39, 52].
A toy example of this application is shown in Table 1. Consider the challenge of learning which genes
among V genes are causally associated with a phenotype Y from a dataset with J patients as the left
side of Table 1 shows. The input data represents the gene expression of patients, and it is used to fit
the level 0 models L1 and L2. The right side of Table 1 shows the output data, constructed with the
learners’ output. We add to the output an attribute with the partially known causes of the application.
The main contributions of this paper are as follows:
• We introduce the problem of causal inference from observational data with partially known
causes. We are the first ones to formalize it as a stacking problem.
• We propose ParKCa, a flexible method that learns new causes from the outputs of causal
inference methods and from partially known causes.
• ParKCa is validated on a real-world TCGA dataset for identifying genes that are potential
causes of cancer metastases and on simulated genomic datasets.
2 Related Work
Our work combines several research areas, and we briefly discuss related work from these areas:
Causality: Motivated by the need for models that are more robust, more reproducible, and easier
to explain, causality has been receiving much attention. Constraint-based causal discovery methods
and their fast version such as the PC-algorithm [44], fast PC-algorithm [29], FCI [45], RFCI [7]
are still largely used. Their main goal is to recover the causal structure by finding a DAG that fits
the observed data. However, even the fast version of these constraint-based approaches have a poor
performance on large dimensional datasets. The RFCI is the method that scales the best, and it was
tested on applications with 6k variables. This size, however, is still a low limit for some applications.
The score-based method fGES [36] based on GES [22] has a good performance on large datasets, yet
it assumes no unobserved confounders. This assumption does not hold in many scenarios, such as
computational biology applications.
There are many methods to estimate treatment effect, and deep learning models are making significant
contributions in the past years with the BLR and BNN [23], CEVAE [33], Dragonnet [42], and others
[41, 61]. Using a different approach, Hill [21] proposed to use the random forest model BART [6]
with CATE [1, 25] to estimate the treatment effect. Finally, a work that has received much attention
recently, the Deconfounder Algorithm (DA) proposed by Wang and Blei [55], combines probabilistic
factor models and outcome models to estimate causal effects. Considering the challenge of learning
causes from several datasets, Tillman and Spirtes [50] proposed a method to learn equivalence
classes from multiple datasets. A limitation of this work, however, is the lack of scalability to large
dimensional datasets.
Ensembles: Our work is based on the stacking ensemble learning proposed by Wolpert [59]. Differ-
ently from boosting[16, 17] and bagging[3], its main idea is to use several learners models whose
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outputs are combined and used as input for a meta-model. The idea of using an ensemble approach to
calculate causal effects is not new [40, 27]. Our work, instead of using ensemble learning to make
more accurate causal effect estimates, focuses on using ensemble learning to discover new causes.
Besides commonly used meta-learner models (Logistic Regression, Random Forest, Neural Networks,
and others), we also explore PU-learning classification models [31, 30, 32, 15, 18, 12], a sub-class of
semi-supervised learning. Our method performs a classification task with the meta-learner on the
level 1 data D1V×L and a new variable that encodes the known causes. The labels are Y
1
v = 1 for
well-known causes and Y 1v = 0 for non-causal or unknown causes. In other words, the classification
learns from positive (known causes) and unlabeled (not causal or unknown causes) data. While the
interpretation is not the same, traditional binary classification models, such as Logistic Regression,
Random Forest Classification [4], Ensemble [11], and SVM [47], can still be used.
Driver Gene Discovery (real-world dataset): Spurious correlations or associations between genes
and metastasis are common. Therefore, the challenge lies in identifying those genes that are true
causes (driver genes) of the underlying condition, not just associated with it. In our real-world dataset,
we want to find genes that contribute to cancer metastasis development. In this condition, cancer
spreads from the original site to other areas of the body. Previous methods that explored this applica-
tion are: MuSiC [10], OncodriveFM [20], ActiveDriver [37], TUSON [9], OncodriveCLUST [49],
MutsigCV [28], OncodriveFML[34], 20/20+ (https://github.com/KarchinLab/2020plus),
and others [53, 39]. The first challenge of this application is the large number of genes (possible
causes) along with the small sample size and the known (and unknown) dependencies among genes,
which adds a certain complexity to the problem. The existence of confounders, some possible to be
observed (such as clinical information), others not (such as family history or lifestyle) [46] poses
another challenge. Finally, the limited and biased list of well-known driver genes [19] also needs
some attention [52]. This list, here referred to as Cancer Gene Census (CGC), is the gold-standard of
driver genes currently available, based on clinical or laboratory results and computational methods
that aim to identify driver genes.
3 The ParKCa Method
ParKCa deals with causal discovery from a stacking ensemble perspective with some adaptations.
Typically, each causal discovery method is estimated individually, and their results compared. In
ParKCa, we use the causal discovery methods’ outputs as features of a classification model to learn
how these methods agree to identify new causes based on a few known causes used as examples.
According to the stacking nomenclature, the causal discovery methods are our learners, and the
classification model is our meta-learner, as shown in Figure 1.
Figure 1: Illustration of the ParKCa method. From d datasets/subsets with Jd columns (examples)
and V rows (possible causes), L× d outputs are extracted using L level 0 models. These outputs are
aggregated in a single dataset D1V×(L∗d). In this step, we also add the partially known causes Y
1 and
fit a meta-learner model to predict new potential causes.
Compared to a standard stacking model, the first modification required by our approach is how we
feed the learners. Different from stacking used as a predictive model, where the goal is to maximize
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the accuracy of the predictions, here we focus on the features (potential causes). Therefore, a learners
fL receives a transpose(D0V×J) as input data. The outcome of interest Y
0
J can be easily added using
the transposed level 0 data. In our real-world dataset, Y 0 encodes if the patient had cancer metastasis
or not. The learners’output is one value per feature v ∈ {1, ..., V }. The second modification is
how we create level 1 data. Traditionally, to avoid data leaking and overfitting, stacking learning
models use cross-validation to make the predictions used on level 1 data. The same is not possible in
our approach: subsets of the possible causes would violate assumptions, such as causal sufficiency.
Instead, we use bootstrapping on the transposed level 0 data. By doing so, we can decrease biases
and test the significance of coefficients when suitable.
All assumptions that the learners make, such as discrete treatments, also need to be satisfied. ParKCa
requires the number of possible causes V to be sufficiently large to be able to fit the meta-learner. As
an ensemble method, ParKCa requires sufficient diversity among the learners. We check the diversity
with the averaged Q statistics[26] over all pairs of classifiers. Considering two learners, fi and fj ,
and the number of True Positives (TP), True Negatives (TN), False Positives (FP) and False Negatives
(FN) from a confusion matrix between the two learners, the Q Statistic is Qi,j = TP×TN−FP×FNTP×TN+FP×FN ,
and Qi,j ∈ [−1, 1]. The diversity increases when the learners commit errors in different objects,
resulting in a negative or close to zero Qi,j . For L learners, the average Q is defined as:
Qav =
2
L(L− 1)
L−1∑
i=1
L∑
j=i+1
Qi,j (1)
3.1 Learners
ParKCa starts by fitting the learners, also called level 0 models. As Figure 1 shows, the
transpose(D0V×J) is the input of the learners fl,∀l ∈ [1, L]. The level 0 models of ParKCA
are causal discovery methods or models that estimate the treatment effect, and their output concate-
nated is the level 1 data D1V×L. The learners employed must have all their assumptions satisfied
for the validity of the results. The Deconfounder Algorithm (DA) [55], for example, requires a
predictive check of its latent variables. Therefore, it is necessary to verify if the factor model passes
the predictive check.
The level 1 data, D1V×L, can have continuous or discrete values. Defining φ(v,l) as the outcome
from learner fl and potential cause v, the value φ(v,l) can be continuous or discrete depending on the
outputs of the learners. Optionally, one might choose to set all non-causal variables to 0. In this case,
if v is a non-causal variable according to method fl, then D1v×l = 0, else, D
1
v×l = φ(v,l).
Some methods, such as models that estimate treatment effects, might benefit from using bootstrapping
to decrease biases and, when suitable, perform a statistical test for H0 : φ(v,l) = 0 or H1 : φ(v,l) 6= 0.
To use bootstrap, we suggest the following steps:
• TakeB samples of size J ′ = b0.9∗Jc from transpose(D0J×V ) and fit the learner fl in each
sample D0J′×V saving the estimated outputs φ(v,l),b; then, set D
1[v, l] = 1B
∑B
b=1 φ(v,l),b
(Strong Law of Large Numbers from Durrett [13])
• (Optional) Apply a two-tailed test to check the hypothesis test with the sample
{φ(v,l),1, ..., φ(v,l),B}. If p-value ≤ 0.05, reject H0 and set D1[v, l] = 1B
∑B
b=1 φ(v,l),b,
else D1[v, l] = 0.
According to the Strong Law of Large Numbers [13], let {φ(v,l),1, ..., φ(v,l),B} be independent
identically distributed random variables with E|φ(v,l),b| < ∞, then the average of the samples
converges to the true mean when B is sufficient large.
As previously mentioned, ParKCa assumes that the number of possible causes V is sufficiently large
to fit a meta-learner. Therefore, the learners must be robust to large datasets. A few examples are the
RFCI [7] and fGES[36] work well in applications where there are no unobserved confounders; the
PC-algorithm fast[29] is robust to unobserved confounders, but its performance in large datasets is
poor; the DA [54] and CEVAE[33] are suitable to applications with unobserved confounders.
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To validate ParKCa, in the experiments we worked with three methods: the Deconfounder Algorithm
(DA)1 [55], BART [6, 21], and CEVAE [33]. The main idea behind DA is to learn latent features as
a substitute for unobserved confounders. Then, use the data augmented with the latent variables to
make the causal inference through an outcome model. The use of proxies to replace true confounders
in causal inference analysis [24, 2] will also be employed on the BART model. BART makes data
interventions to estimate the conditional average treatment effect (CATE) [1, 25]. For each possible
cause v ∈ {1, ..., V }:
CATEv = E[Y |X = x, do(Xv = a), Z]− E[Y |X = x, do(Xv = 0), Z] (2)
where Xv = 0 represents the intervention component on the observed data Xv = a and Z the
estimated proxies. Finally, CEVAE infers causal effects from observational data and is robust to
unobserved confounders. Based on Variational Autoencoders (VAE), it tries to simultaneously
discover the hidden confounders and infer how they affect the treatment and output.
The learners of our experiments were selected to satisfy the requirements and assumptions of the
application. We would like to emphasize that ParKCa is not limited to these learners.
3.2 Meta-learner
The level 1 dataset D1V×L records the outputs of L learners for V possible causes. If multiple level 0
datasets are being used, then the format is D1V×L∗d, where d is the number of level 0 datasets (see
Figure 1). The prior knowledge about known causes is added as a new attribute Y 1, where Y 1v = 1 if
v is a known cause, and 0 otherwise. Note that, unless all the possible causes are known, some true
causes will be labeled as 0. ParKCa uses binary classification models as meta-learners. The level 1
data contains only positive or unlabeled examples, so we tested PU-learning classification models
and compared their results with traditional classification models (Logistic Regression (LR), Random
Forest (RF), and Neural Network (NN)).
The PU-learning model Adapter-PU proposed by Elkan and Noto [15] uses a traditional probabilistic
classifier co(X) such that co(X) = p(Y = 1|X) is as close as possible. The assumption is that
the labeled positive examples are completely random. Unbiased PU (UPU) proposed by Du Plessis
et al. [12] is another PU-learning model adopted. UPU is a convex classification method that aims to
cancel the bias from the unlabeled data being a mix of positive and negative examples by using a loss
function for positive examples and another loss function for unlabeled examples.
The traditional binary classification models consider all unlabeled examples as negatives examples or
non-causal variables, which can add bias and noise to the predictions. A majority vote ensemble from
the methods described above is also used. Finally, a random model is also compared. The random
model assigns the labels 1 and 0 according to the proportion of 1’s and 0’s in the training data.
4 Experiments
We performed experiments to validate our method on two Genome-wide association studies (GWAS)
datasets, a real-world dataset, and a simulated dataset.
Real-world dataset: We use The Cancer Genome Atlas Program (TCGA) dataset, which has
available the gene expression (RNA-seq) of patients with cancer. The data pre-processing is described
in the Supplemental Material, and the final level 0 dataset from this application has 7066 genes and
2854 patients, of which 1039 (36%) have metastases. From the 7066 genes, 681 (9%) are known
driver genes [19]. These known driver genes are our positive examples in the meta-learner models.
For this application, we also worked with multiple datasets considering their clinical information,
such as gender and cancer type.
Simulated datasets: We simulated GWAS data following the scheme described by Wang and
Blei [55] and Song et al. [43], illustrated with more details in the Supplemental Material. Single
nucleotide polymorphisms (SNPs), the most common type of genetic variation among people, is the
datatype adopted. We simulated 10 independent datasets, with 5000 individuals and 10000 SNPs,
and confounders. 10% of these SNPs were set to be causal of a binary trait.
1There is an ongoing discussion about DA, with some recent criticism [35, 14, 8] and extra clarification
[56, 57] presented. ParKCa assumes that the work developed by Wang and Blei [55] is correct. However, in case
the reader is uncomfortable with the use of this method, we recommend to replace it with other suitable learner.
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To validate our method, we first evaluate the learners adopted. Then, we check if ParKCa indeed
contributes to detecting more causes. We also verify for the simulated dataset if ParKCa can be
used to make better estimates of the treatment effect. Finally, as an extra analysis, we compare our
results in the real-world dataset with the state-of-art methods in driver gene discovery. We say ‘extra’
because these methods are not standard causal discovery methods but aim to solve the same problem.
Evaluation of the learners: To evaluate the learners, we first analyze the ROC curves of the learners
on level 0 data; we also test the DA’s predictive check and the convergence of the CEVAE. We
adopted DA with the probabilistic PCA [51] as a factor model and Logistic Regression with the
elastic net as an outcome model. In our experiments, increasing the number of the latent variables did
not improve the results (See Supplemental Material); thus, we adopted k = 15.
(a) Simulated datasets (b) Real-world dataset.
Figure 2: ROC curves of the learners. See Supplemental Material for more.
To construct the ROC curves shown in Figure 2, we split the transposed dataset D0V×J into training
(67%) and testing set (33%). Thus, each set has all the possible causes and a subset of the samples.
Using the models fitted on the training set, we predicted the outputs for the testing set, which is the
outcome of interest at level 0. We used 12 learners on the real-world dataset: BART + 3 datasets
(all patients, female and male patients), and DA + 9 datasets (all patients, female and male patients,
and six groups of patients with same cancer type). All level 0 models had an excellent performance,
as shown in Figure 2b, except for 4 DA models constructed using datasets based on cancer type.
Therefore, we removed the outputs obtained through datasets based on cancer types ESCA, LIHC,
PAAD, and SARC from the level 1 dataset. In the simulation study, we repeated the experiment ten
times, once for each simulated dataset, and reported the rate of True Positives and False Positives
using either CEVAE or DA for each repetition. All learners had a good performance in predicting
the outcome of the level 0 datasets as the ROC curves show in Figure 2a. The DA models passed
the predictive check with k = 15 (average p-value= 0.7181 at real-world dataset and 0.5381 on the
simulated dataset). The CEVAE’s convergence plots indicate that the model converges after 40 epochs
on average. Some randomly selected convergence plots are shown in the Supplemental Material.
The last step of the learners’ evaluation is checking the diversity among the final level 0 models
measured by Qav. Negative values of Qav indicate diversity because the learners are committing
errors on different objects. The learners used on the real-world dataset about driver gene discovery
has diversity equal to −0.013, and the average diversity of the learners used with the simulated
dataset was −0.051, from which we conclude there is diversity among the learners adopted in our
experiments.
Learners versus Meta-Learners: This comparison is the core of our validation process. Here, we
investigate if adding an extra layer in ParCKa, the meta-learner, contributes to discovering more
causes. Therefore, we compare the learners and the meta-learners capacity of identifying causal
variables. The learners, which are causal discovery methods or methods to estimate treatment effects,
are used individually to predict if a variable is causal according to their metrics and definitions. These
predictions are compared with the meta-learners’ predictions Yˆ 1.
The DA considers variables significantly different from 0 in the outcome model as a causal variable.
BART and CEVAE do not have a similar metric, and they only provide treatment effect estimates.
One option is using the bootstrap method explained earlier to fit a confidence interval and check
if the treatment effect estimated is significantly different from zero. In our experiments, however,
we obtained better performance by assigning the 10% largest estimated treatment effects as causal
variables and setting the other variable as non-causal. The learners are compared individually against
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(a) Real-world dataset: Comparison between learners
and ParKCa meta-learners to identify causes on the
Level 1 test set.
(b) Simulated dataset: Comparison to identify causes
on the level 1 test set with different proportions of
known causes. Large F1-score indicate good models.
(c) Simulated dataset: PEHE on the level 1 test set. Small PEHE indicates good models.
Figure 3: Causal discovery task evaluation. The learners consider only the original data; ParKCA
meta-learners use the learners’ outputs and partially known causes to identify more causes.
6 meta-learners (UPU, Adapted-PU, Logistic Regression - LR, Random Forest - RF, Neural Network
- NN, Ensemble - E), and a random model. To perform a fair comparison between learners and
meta-learners, we split the level 1 data into training and testing sets. We calculated the precision
and recall using only the predicted values for the testing set. The results for the real-world data are
shown in Figure 3a. While meta-learners and learners models have similar precision, meta-learners
tend to have much better recall then learners. Overall, ParKCa has fewer causal variables undetected
(False Negatives) than the learners. Figure 3b shows the average F1-score on the simulated datasets
versus the proportion of known causes. The proportion of known causes represents how much of
the true causes ParCKa has access: if ParKCa knows 40% of the causes, during the training phase,
we randomly label 40% of the true causes as 1 and the other 60% as 0, to replicate what we usually
encounter in the real-world. We observe that even when ParKCa can access to only a small proportion
of true causes, it performs better than the existing baselines, which are independent of the percentage
of known causes. The meta-learners, except for the RF, have a higher average F1-score even when
only 10% of the causes are known. These results validate our claim that the ParKCa approach can
identify more causes then existing methods when some causes are known.
Treatment Effect Estimates: We investigate a secondary result of the learners used on the simulated
datasets, the estimation of treatment effect. We compare the Precision in Estimation of Heterogeneous
Effect (PEHE)[21, 33] of our approach against that of the learners used in dependency from the
percentage of known causes. PEHE = 1N
∑N
i=1((yi1 − yi0)− (yˆi1 − yˆi0)), where yi1 and yi0 are
the true treatment effects, and yˆi1 and yˆi0 are the estimated treatment effects. This scenario is hard to
perform in a real-world dataset with ParKCa due to the need for known treatment effect estimates,
which are more difficult to obtain. However, this experiment can easily be performed on a simulated
dataset. We adopted a simple linear regression model as a meta-learner, and we split the level 1 data
into training and testing sets. We compared the PEHE of the meta-learner with CEVAE and DA on
the test set. Figure 3c shows the PEHE for the causal variables in the left and for all variables on the
right. The average PEHE for the ParKCa meta-learner is similar to that of DA when only 10% of the
causes are known; however, it decreases when more causes are known in both plots. These results
point out an alternative use of ParKCa for treatment effect estimation.
(Extra) Comparison between ParKCa and other baselines: We compared our results from the
real-world dataset with reported results from eight driver gene discovery methods analyzed using
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(a) (b)
Figure 4: (Real-world dataset) Comparison between driver gene discovery baselines and ParCKa.
The goal is to predict driver genes (causal variables) correctly. Large Recall, Precision, and F1-score
indicate good models. The score reported is from the full real-world dataset.
the Cancer Gene Census (CGC) [52]. The baselines are MutsigCV, ActiveDriver (AD), MuSiC,
OncodriveCLUST (ODC), OncodriveFM (ODFM), OncodriveFML (ODFML), TUSON, and 20/20+.
Their approaches vary from analysis of somatic point mutations, mutation significance, functional
impact and clusters of somatic mutations, and Random Forest of previous driver genes methods.
These baselines are not considered causal discovery methods, which is why we did not use them
as learners, but are strong methods that try to solve the same problem on the real-world dataset.
We remind the reader that ParKCA takes partial knowledge of causal genes and genomic data as
input, while the compared methods only have genomic data as input, but use multiple and more
sophisticated types of genomic data. We used the results reported by Tokheim et al. [52].
Before interpreting Figure 4, it is essential to point out that the choice of what is considered a good
driver gene discovery model is also an open question. Large recall and small precision indicate
models that can recover many known driver genes at the cost of a high rate of False Positives (FP).
One can interpret this as a bad model because the true driver genes are lost in the middle of the FP,
while others might think that this is an indication of a larger number of unknown driver genes yet to
be discovered and explored. On the other hand, high precision and low recall indicate models good at
identifying certain driver genes; however, they fail to identify a broader range of them, reflected by a
large number of False Negatives (FN). The F1-score summarizes these measures by giving the same
importance to both of them. Figure 4a indicates that ParKCA meta-learners have a larger recall (0.69
on average) and smaller precision (0.16 on average). On the other hand, the baselines have lower
recall (0.17 on average) and larger precision (0.28 on average). Figure 4b shows that ParKCA with
RF has the largest F1-score, which is almost the double of the largest F1-score from the baseline
methods. Overall, ParKCa has competitive results when compared to existing driver gene discovery
methods.
5 Discussion and Conclusion
Our proposed method ParKCa demonstrated excellent results in the experiments. For small percent-
ages of known causes, Adapter-PU was the meta-learner with the best performance. Furthermore,
there was almost no difference between PU models and traditional classification models when the
percentage of known causes was above 70%. If the unlabeled examples are mostly negative, the
contribution that PU methods can make is limited, and PU classification reduces to traditional binary
classification.
While our simulations show the efficacy of our method, we highlight that in practice, the results
crucially depend on the list of known causes. If this list is comprehensive and includes causes of
diverse behaviors and types, ParKCa will likely succeed in its task. On the other hand, if the list is
biased towards certain characteristics, our method might only identify causes with behavior similar
to the known examples. In conclusion, we believe our proposed method ParKCa makes important
contributions to causal inference. ParKCa exploits partial knowledge of causes, is flexible, robust,
easy to use and demonstrated promising results on a real-life dataset and in simulations.
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Broader Impact
Our work, while primarily agnostic to the type of application, is especially suitable for computational
biology problems. In this context, our method aims to identify causal associations between genomic
data and traits, such as diseases or adversarial drug effects. Identifying such causal associations has
the potential for positive impacts: knowledge to help track and recognize diseases in the early stages,
identify high-risk groups of patients, recommend personalized treatments for an individual based on
their genomic data, among other benefits from precision medicine. Identifying causal associations
between genomic data and traits, however, can be used for immoral purposes. Health care providers,
for example, might charge higher prices for health care plans given the information that a person
has a particular gene mutation associated with some disease. We currently rely on the fact that it is
illegal for these companies to get access to this data without the patient’s consent. With the increasing
number of researchers using genomic data and also the growing number of available datasets, we
hope that regulations will be created or improved to control and regulate this very sensitive data and
stop the misuse of such information.
As a Machine Learning method, ParKCa is susceptible to any bias that might be present in the dataset.
If the known causes used are biased, then the new causes discovered by the method are likely also to
be biased. In the same way, if the dataset is representative only of a specific population, the results
can be generalized only for the same population. In this case, ParKCa results should be used and
interpreted in the same way most other data-based methods are: keeping in mind the data dependency.
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